Skip to main content
Log in

Neuropharmacological characterization of local ibogaine effects on dopamine release

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Local perfusion with ibogaine (10−6M—10−3M) via microdialysis probes in the nucleus accumbens or striatum of rats produced a biphasic dose-response effect on extracellular dopamine levels. Lower doses (10−6M—10−4M) produced a decrease while higher doses (5 × 10−4M—10−3M) produced an increase in dopamine levels. Dihydroxyphenylacetic acid (DOPAC) levels were not effected. Naloxone (10−6M) and norbinaltorphimine (10−6M—10−5M) did not affect dopamine levels, but when co-administered with ibogaine (10−4M) blocked the decrease in dopamine levels produced by ibogaine. Ibogaine (10−3M) stimulation of dopamine levels in the striatum was calcium independent and not blocked by tetrodotoxin (10−5M). Pretreatment with cocaine (15mg/kg), reserpine (5mg/kg) or alpha-methyl-paratyrosine (250mg/kg) given intraperitoneally significantly reduced ibogaine (10−3M) stimulation of striatal dopamine levels. In striatal synaptosomes, both ibogaine and harmaline (10−7—10−4M) produced dose-dependent inhibition of [3H]-dopamine uptake. These findings suggest that ibogaine has both inhibitory and stimulatory effects on dopamine release at the level of the nerve terminal. It is suggested that the inhibitory effect is mediated by kappa opiate receptors while the stimulatory effect is mediated by interaction with the dopamine uptake transporter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Alexander GM, Grothusen JR, Schwartzman RJ (1988) Flow dependent changes in the effective surface area of microdialyis probes. Life Sci 43: 595–601

    Google Scholar 

  • Bogdanski DF, Brodie BB (1969) The effects of inorganic ions on the storage and uptake H3-norepinephrine by rat heart slices. J Pharmacol Exp Ther 165: 181–189

    Google Scholar 

  • Broderick PA (1987) Striatal neurochemistry of Dynorphin-(1-13): in vivo electrochemical semi-differential analysis. Neuropeptides 10: 369–386

    Google Scholar 

  • Broderick PA, Phelan FT, Eng F, Wechsler RT (1994) Ibogaine modulates cocaine responses which are altered due to environmental habituation: in vivo microvoltammetric and behavioral studies. Pharmacol Biochem Behav 49: 711–728

    Google Scholar 

  • Cappendijk SLT, Dzoljic MR (1993) Inhibitory effects of ibogaine on cocaine self-administration in rats. Eur J Pharmacol 241: 261–265

    Google Scholar 

  • Carboni E, Imperato A, Perezanni L, DiChiara G (1991) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28: 653–661

    Google Scholar 

  • Crawford CA, McDougall SA, Bolanos CA, Hall S, Berger SP (1995) The effects of the kappa agonist U-50,488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivity. Psychopharm 120: 392–399

    Google Scholar 

  • Deecher DC, Teitler M, Soderlund DM, Bornmann WG, Kuehne ME, Glick SD (1992) Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies. Brain Res 571: 242–247

    Google Scholar 

  • Drucker G, Raikoff K, Neafsey NJ, Collins MA (1990) Dopamine uptake inhibitory capacities of beta-carboline and 3,4-dihydro-beta-carboline analogs of N-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP) oxidation products. Brain Res 509: 125–133

    Google Scholar 

  • Fischer JF, Cho AK (1979) Chemical release of dopamine from caudate-putamen homogenate: evidence for an exhange diffusion model. J Pharmacol Exp Ther 208: 203–209

    Google Scholar 

  • Florin SM, Kuczenski R, Segal DS (1995) Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral consideration. J Pharmacol Exp Ther 274: 231–241

    Google Scholar 

  • Fujise H, Hamada Y, Mori M, Ochiai H (1995) Na-dependent glutamate transport in high K and High glutathione (HK/HG) and high L low glutathione (HK/LG) dog red blood cells. Biochem Biophys Acta 1239: 22–26

    Google Scholar 

  • Glick SD, Rossman K, Steindorf S, Maisonneuve IM, Carlson JN (1991) Effects and aftereffects of ibogaine on morphine self-administration in rats. Eur J Pharmacol 195: 341–345

    Google Scholar 

  • Glick SD, Rossman K, Wang S, Dong N, Keller Jr RW (1993) Local effects of ibogaine on extracellular levels of dopamine and its metabolites in nucleus accumbens and striatum: interactions with d-amphetamine. Brain Res 628: 201–208

    Google Scholar 

  • Harsing Jr LG, Sershen H, Lajtha A (1994) Evidence that ibogaine releases dopamine from the cytoplasmic pool in isolated mouse striatum. J Neural Transm [Gen Sect] 96: 215–225

    Google Scholar 

  • Heidbreder CA, Goldberg SR, Shippenberg TS (1993) The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res 616: 335–338

    Google Scholar 

  • Hernandez L, Hoebel BG (1988) Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Life Sci 42: 1,702–1,705

    Google Scholar 

  • Hurd YL, Ungerstedt U (1989a) In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur J Pharmacol 166: 251–260

    Google Scholar 

  • Hurd YL, Ungerstedt U (1989b) Influence of a carrier transport process on in vivo release and metabolism of dopamine: dependence on extracellular Na+. Life Sci 45: 283–293

    Google Scholar 

  • Janowsky A, Berger SP, Vocci F, Labarca R, Skolnick P, Paul SM (1986) Characterization of sodium dependent [3H]-GBR 12935 binding in brain: a radioligand for selection labeling of the dopamine transport complex. J Neurochem 46: 1,274–1,276

    Google Scholar 

  • King SM, Tunnicliff G (1990) Na(+)- and Cl(−)-dependent [3H]GABA binding to catfish brain brain particles. Biochem Intl 20: 821–831

    Google Scholar 

  • Kscha U, Farber SA, Marshall D, Wurtman RJ (1993) Carbachol and naloxone synergistically elevate dopamine release in rat striatum: an in vivo microdialysis study. Brain Res 613: 288–290

    Google Scholar 

  • Lindefors N, Amberg G, Ungerstedt U (1989) Intracerbral microdialysis. I. Experimental studies of diffusion kinetics. J Pharmacol Meth 22: 141–156

    Google Scholar 

  • Maisonneuve IM, Glick SD (1992) Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior. Eur J Pharmacol 212: 263–266

    Google Scholar 

  • Maisonneuve IM, Keller Jr RW, Glick SD (1991) Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study. Eur J Pharmacol 199: 35–42

    Google Scholar 

  • Maisonneuve IM, Keller Jr RW, Glick SD (1992) Interactions of ibogaine and damphetamine: in vivo microdialysis and motor behavior in rats. Brain Res 579: 87–92

    Google Scholar 

  • Maisonneuve IM, Archer S, Glick SD (1994) U50,488 a kappa opioid agonist attenuates cocaine induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci Lett 181: 57–60

    Google Scholar 

  • Mash DC, Staley JK, Baumann MH, Rothman RB, Hearn WL (1995) Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin. Life Sci 57: PL45-PL50

    Google Scholar 

  • McMillen BA, German DC, Shore PA (1980) Functional and pharmacological significance of brain dopamine and norepinephrine storage pools. Biochem Pharmacol 29: 3,045–3,050

    Google Scholar 

  • Newman EA (1991) Sodium-bicarbonate cotransport in retinal Muller (glial) cells of the salamander. J Neurosci 11: 3,972–3,983

    Google Scholar 

  • Osborne PG, O'Connor WT, Drew KL, Ungerstedt U (1990) An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake, freely moving and halothane anaesthetized rats. J Neurosci Meth 34: 99–105

    Google Scholar 

  • Paton DM (1973) Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atria. Br J Pharmacol 49: 614–627

    Google Scholar 

  • Pearl SM, Herrick-Davis K, Teitler M, Glick SD (1995) Radioligand binding study of noribogaine, a likely metabolite of ibogaine. Brain Res 675: 342–344

    Google Scholar 

  • Popik P, Layer RT, Skolnick P (1994) The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]-MK-801 binding to the NMDA receptor complex. Psychopharm 114: 672–674

    Google Scholar 

  • Sershen H, Hashim A, Harsing L, Abel L (1992) Ibogaine antagonizes cocaine-induced locomotor stimulation in mice. Life Sci 50: 1,079–1,086

    Google Scholar 

  • Sershen H, Hashim, Lajtha A (1995) The effect of ibogaine on kappa-opioid and 5-HT3-induced changes in stimulation evoked dopamine release in vitro from striatum of C57BL/6By mice. Brain Res Bull 36: 587–591

    Google Scholar 

  • Spanagel R, Herz A, Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55: 1,734–1,740

    Google Scholar 

  • Spanagel R, Herz A, Shippenberg TS (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89: 2,046–2,050

    Google Scholar 

  • Spealman RD, Bergman J (1992) Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther 261: 607–615

    Google Scholar 

  • Stahle L, Segersvard S, Ungerstedt U (1991) A comparison between three methods for estimation of extracellular concentrations of exongenous and endogenous compounds by microdialysis. J Pharmacol Meth 25: 41–52

    Google Scholar 

  • Suzuki T, Shiozaki Y, Masukawa Y, Misawa M, Nagase H (1992) The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference. Jpn J Pharmacol 58: 435–442

    Google Scholar 

  • Sweetnam PM, Lancaster J, Snowman A, Collins JL, Perschke S, Bauer C, Ferkany J (1995) Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity. Psychopharm 118: 369–376

    Google Scholar 

  • Van Winkle LJ, Campione AL, Mann DF, Wasserlauf HG (1993) The cation receptor subsite of the choline transporter in preimplation mause conceptus resembles a cation receptor subsite of several amino acid transporters. Biochim Biophys Acta 1146: 38–44

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reid, M.S., Hsu, K., Souza, K.H. et al. Neuropharmacological characterization of local ibogaine effects on dopamine release. J. Neural Transmission 103, 967–985 (1996). https://doi.org/10.1007/BF01291787

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01291787

Keywords

Navigation